Boston University Cross-Disciplinary Training in Nanotechnology for Cancer

波士顿大学癌症纳米技术跨学科培训

基本信息

项目摘要

DESCRIPTION (provided by applicant): Cancer is a scourge on the face of humanity, responsible for over 550,000 deaths in 2008 in the US, one out of every four. New diagnoses this year will top 1.4 million, with projections only growing as the population ages. From a global health perspective, the vast majority of cancer deaths occur in low and middle income countries, and the incidence and death rate is rising in these countries, adding to our urgency to improve prevention and treatment. The promise of nanotechnology in cancer lies in the ability to engineer customizable nanoscale constructs that can be loaded with one or more payloads such as chemotherapeutics, targeting units, imaging and diagnostic agents. Nanotechnology holds great promise for cancer, with the potential to address many difficult problems now facing cancer prevention, diagnosis, and therapy. These include the application of nanotechnology to early detection/cancer prevention, through identification of rare circulating tumor cells. Proteomics in particular is emerging as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumors stage. Nanowires and nanocantilever arrays are among the leading approaches under development for the early detection of precancerous and malignant lesions from biological fluids. Nanobiotechnologies have been applied to improve drug delivery and to overcome some of the problems of drug delivery in cancer. Enhancing the activity and specificity of radiation therapy by sensitization of tumor tissues to radiation through nanoparticle targeting of tumor tissue is an approach currently in clinical testing. Nanoparticles are also being used for gene therapy for cancer. Targeting of the tumor environment, rather than the tumor itself, could be facilitated by nanoparticle-mediated gene delivery to tumor neovasculature. With potential advances in therapy garnered through nanotechnology, significant improvements in tumor imaging will be required for their effective application. New technology allowing sensitive detection of residual disease, and molecular characterization of these minimal residual cancer cells in patients with solid tumors, will be critical in determining the length of a course of treatment, saving the patient potential toxicity and expense. In the proposed training center proposal, we endeavor to do just that, directly couple faculty and students from physical and biological sciences on our Charles River Campus with the medical researchers and clinicians on our Medical Campus. Our program creates mechanisms for connections between the campuses with co-mentoring, cross-fertilized research projects, and interdisciplinary courses and workshops, easily overcoming the simple physical barrier of a mile of asphalt, and leading participants on the way to surmount the more challenging scientific cultural and disciplinary barriers. PUBLIC HEALTH RELEVANCE: The promise of nanotechnology in cancer lies in the ability to engineer customizable nanoscale constructs that can be loaded with one or more payloads such as chemotherapeutics, targeting units, imaging and diagnostic agents. Nanotechnology thus holds great promise for cancer, with the potential to address many of the most difficult problems now facing cancer prevention, diagnosis, and therapy. Boston University is building a cross-disciplinary training program to train the next generation of scientists, engineers and researchers to fulfill this promise.
描述(由申请人提供):癌症是人类面临的一个祸害,2008年在美国造成超过55万人死亡,每四人中就有一人死亡。今年的新诊断将超过140万,随着人口老龄化,预测只会增长。从全球健康的角度来看,绝大多数癌症死亡发生在中低收入国家,这些国家的发病率和死亡率正在上升,这增加了我们改善预防和治疗的紧迫性。纳米技术在癌症中的前景在于设计可定制的纳米级结构的能力,这些结构可以装载一种或多种有效载荷,如化疗药物,靶向单位,成像和诊断剂。纳米技术为癌症带来了巨大的希望,有可能解决癌症预防、诊断和治疗所面临的许多难题。其中包括通过识别罕见的循环肿瘤细胞,将纳米技术应用于早期检测/癌症预防。特别是蛋白质组学正在成为检测核基质蛋白和筛选早期肿瘤阶段的新生物标志物的工具。纳米线和纳米悬臂阵列是正在开发的用于从生物流体中早期检测癌前病变和恶性病变的主要方法之一。纳米生物技术已被应用于改善药物递送和克服癌症中药物递送的一些问题。通过靶向肿瘤组织的纳米颗粒使肿瘤组织对辐射敏感来增强放射治疗的活性和特异性是目前临床测试中的一种方法。纳米颗粒也被用于癌症的基因治疗。靶向肿瘤环境,而不是肿瘤本身,可以通过纳米粒子介导的基因递送到肿瘤新生血管来促进。随着纳米技术在治疗方面的潜在进展,肿瘤成像的显着改进将需要其有效应用。新技术允许残留疾病的灵敏检测,以及实体瘤患者中这些最小残留癌细胞的分子表征,将在确定疗程长度,节省患者潜在毒性和费用方面至关重要。在拟议的培训中心提案中,我们奋进做到这一点,直接将查尔斯河校区物理和生物科学的教师和学生与我们医学校区的医学研究人员和临床医生联系起来。我们的计划创造了校园之间的联系机制,共同指导,交叉施肥研究项目,跨学科课程和研讨会,轻松克服一英里沥青的简单物理障碍,并带领参与者克服更具挑战性的科学文化和学科障碍。 公共卫生关系:纳米技术在癌症中的前景在于设计可定制的纳米级结构的能力,这些结构可以装载一种或多种有效载荷,如化疗药物,靶向单位,成像和诊断剂。因此,纳米技术为癌症带来了巨大的希望,有可能解决癌症预防,诊断和治疗目前面临的许多最困难的问题。波士顿大学正在建立一个跨学科的培训计划,以培养下一代科学家,工程师和研究人员,以实现这一承诺。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas V Faller其他文献

Sky-1214, a Small Molecule Splicing Modulator Targeting FANCL and Fanci, Provides a New Mechanism of Action Targeting Multiple Myeloma and Non-Hodgkin's Lymphoma
  • DOI:
    10.1182/blood-2024-209068
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Simone Rauch;Stefan Reber;Montserrat Perez-Salvia;Marco Pregnolato;Botao Liu;Loren Berry;Olesia Buiakova;Hasane Ratni;Brian Gudenas;Carlo Cusulin;Lauren Shanahan;Douglas V Faller;Veronica Costa;Sergey Paushkin
  • 通讯作者:
    Sergey Paushkin
Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial
  • DOI:
    10.1182/blood-2022-168945
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Olga Salamero;Tim C.P Somervaille;Antonieta Molero;Evelyn Acuña-Cruz;Jose A. Perez-Simon;Rosa Coll;Montserrat Arnan;Brayan Merchan;Ana Perez;Isabel Cano;Rebeca Rodríguez-Veiga;Mabel Arevalo;Sonia Gutierrez;Carlos Buesa;Douglas V Faller;Francesc Bosch;Pau Montesinos
  • 通讯作者:
    Pau Montesinos
The Frida Study: An Option for Mutated FLT3 Relapsed/Refractory Acute Myeloid Leukemia Patients with a Novel Iadademstat and Gilteritinib Combination Therapy
  • DOI:
    10.1182/blood-2022-160427
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Amir T. Fathi;Mabel Arevalo;Sonia Gutierrez;Antonieta Molero;Natalia Sacilotto;Ana Limon;Douglas V Faller
  • 通讯作者:
    Douglas V Faller

Douglas V Faller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas V Faller', 18)}}的其他基金

Development of a Clinical Hemoglobin Modulator
临床血红蛋白调节剂的开发
  • 批准号:
    10428368
  • 财政年份:
    2020
  • 资助金额:
    $ 3.27万
  • 项目类别:
Development of a Clinical Hemoglobin Modulator
临床血红蛋白调节剂的开发
  • 批准号:
    10175025
  • 财政年份:
    2020
  • 资助金额:
    $ 3.27万
  • 项目类别:
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
非癌基因成瘾作为胰腺癌的靶向治疗
  • 批准号:
    8601296
  • 财政年份:
    2013
  • 资助金额:
    $ 3.27万
  • 项目类别:
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
非癌基因成瘾作为胰腺癌的靶向治疗
  • 批准号:
    8427550
  • 财政年份:
    2013
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8333431
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8497793
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8136042
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8712186
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8860316
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:
Boston University Cross-Disciplinary Training in Nanotechnology for Cancer
波士顿大学癌症纳米技术跨学科培训
  • 批准号:
    8860315
  • 财政年份:
    2010
  • 资助金额:
    $ 3.27万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Holocene Landscape History in the forest area „Schweinert“ – a geoarchaeological study in Germany’s largest Bronze Age barrow cemetery
森林地区全新世景观历史“Schweinert”——德国最大的青铜时代手推墓地的地质考古研究
  • 批准号:
    452251818
  • 财政年份:
    2020
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Research Grants
Empirical study on the Iron Production of the Early Iron Age in the Area of Altai Extending over Four Countries
阿尔泰地区四国早期铁器时代铁矿生产实证研究
  • 批准号:
    17H01646
  • 财政年份:
    2017
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Religious Paracelsianism: Science and Religion in the German-speaking Area of the Early Modern Age
宗教帕拉塞尔西主义:近代早期德语区的科学与宗教
  • 批准号:
    16K21332
  • 财政年份:
    2016
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Age and significance of permafrost landforms in the Fort McMurray area
麦克默里堡地区多年冻土地貌的年龄和意义
  • 批准号:
    478568-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 3.27万
  • 项目类别:
    University Undergraduate Student Research Awards
Late Neolithic/Early Bronze Age developments in the south-west Baltic area (2500-1500 BC): Why did the Bruszczewo-Leki Male type of power structures appear?
波罗的海西南部地区新石器时代晚期/青铜时代早期的发展(公元前2500-1500年):为什么会出现布鲁什切沃-莱基男性类型的权力结构?
  • 批准号:
    277223019
  • 财政年份:
    2015
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Research Grants
'Ritual feasting' in the Late Bronze Age in the northwestern Carpathian area -archaeological and scientific aspects
喀尔巴阡山脉西北部地区青铜时代晚期的“仪式盛宴”——考古和科学方面
  • 批准号:
    287419687
  • 财政年份:
    2015
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Research Grants
Research on the Folk House of Yeosu Area in a Modern Age -Consideration from a Viewpoint of the Influence of the Ocean Culture Area-
近代丽水地区民居研究-从海洋文化区影响的角度思考-
  • 批准号:
    26420607
  • 财政年份:
    2014
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study about the age and the production area of the Yan Guo and Liaoning Area Remains in the Spring and Autumn Warring States Period
春秋战国时期燕国及辽宁地区遗存的年代及产地研究
  • 批准号:
    25300043
  • 财政年份:
    2013
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The formation process of Tai Hang mountains area in Final stage of Chinese Neolithic age : Focused on analysing pottery
中国新石器时代末期大坑山区的形成过程——以陶器为重点分析
  • 批准号:
    23820059
  • 财政年份:
    2011
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Bronze Age Carian Iasos: Structures, Stratigraphy, and Finds from the area of the Late Roman Agora (ca. 3000-1500 BC)
青铜时代卡里安亚索斯:晚期罗马集市(约公元前 3000-1500 年)地区的结构、地层学和发现物
  • 批准号:
    AH/I001611/1
  • 财政年份:
    2011
  • 资助金额:
    $ 3.27万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了